These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cholinesterase inhibition modulates visual and attentional brain responses in Alzheimer's disease and health. Bentley P; Driver J; Dolan RJ Brain; 2008 Feb; 131(Pt 2):409-24. PubMed ID: 18077465 [TBL] [Abstract][Full Text] [Related]
4. Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. Bentley P; Husain M; Dolan RJ Neuron; 2004 Mar; 41(6):969-82. PubMed ID: 15046728 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer disease constricts the dynamic range of spatial attention in visual search. Parasuraman R; Greenwood PM; Alexander GE Neuropsychologia; 2000; 38(8):1126-35. PubMed ID: 10838147 [TBL] [Abstract][Full Text] [Related]
6. Asymmetries in the covert orienting of visual spatial attention to spatial and non-spatial cues in Alzheimer's disease. Maruff P; Malone V; Currie J Brain; 1995 Dec; 118 ( Pt 6)():1421-35. PubMed ID: 8595474 [TBL] [Abstract][Full Text] [Related]
7. Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory. Bentley P; Driver J; Dolan RJ Brain; 2009 Sep; 132(Pt 9):2356-71. PubMed ID: 19605530 [TBL] [Abstract][Full Text] [Related]
8. Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Raghavendra V; Chopra K; Kulkarni SK Neuropeptides; 1998 Oct; 32(5):417-21. PubMed ID: 9845001 [TBL] [Abstract][Full Text] [Related]
9. Scopolamine slows the orienting of attention in primates to cued visual targets. Davidson MC; Cutrell EB; Marrocco RT Psychopharmacology (Berl); 1999 Feb; 142(1):1-8. PubMed ID: 10102776 [TBL] [Abstract][Full Text] [Related]
10. A novel acetylcholinesterase inhibitor, Ro 46-5934, which interacts with muscarinic M2 receptors. Borroni E; Damsma G; Giovacchini C; Mutel V; Jakob-Rötne R; Da Prada M Biochem Soc Trans; 1994 Aug; 22(3):755-8. PubMed ID: 7821679 [No Abstract] [Full Text] [Related]
11. Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions. Haroutunian V; Greig N; Pei XF; Utsuki T; Gluck R; Acevedo LD; Davis KL; Wallace WC Brain Res Mol Brain Res; 1997 Jun; 46(1-2):161-8. PubMed ID: 9191090 [TBL] [Abstract][Full Text] [Related]
12. Selective impairment of spatial attention during visual search in Alzheimer's disease. Parasuraman R; Greenwood PM; Alexander GE Neuroreport; 1995 Oct; 6(14):1861-4. PubMed ID: 8547585 [TBL] [Abstract][Full Text] [Related]
13. Behavioral characterization of a transection of dorsal CA3 subcortical efferents: comparison with scopolamine and physostigmine infusions into dorsal CA3. Hunsaker MR; Rogers JL; Kesner RP Neurobiol Learn Mem; 2007 Jul; 88(1):127-36. PubMed ID: 17350296 [TBL] [Abstract][Full Text] [Related]
14. Scopolamine induces disruption of latent inhibition which is prevented by antipsychotic drugs and an acetylcholinesterase inhibitor. Barak S; Weiner I Neuropsychopharmacology; 2007 May; 32(5):989-99. PubMed ID: 16971898 [TBL] [Abstract][Full Text] [Related]
15. Cholinergic agents and delay-dependent performance in the rat. Buxton A; Callan OA; Blatt EJ; Wong EH; Fontana DJ Pharmacol Biochem Behav; 1994 Dec; 49(4):1067-73. PubMed ID: 7886077 [TBL] [Abstract][Full Text] [Related]
16. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Sahakian BJ; Owen AM; Morant NJ; Eagger SA; Boddington S; Crayton L; Crockford HA; Crooks M; Hill K; Levy R Psychopharmacology (Berl); 1993; 110(4):395-401. PubMed ID: 7870908 [TBL] [Abstract][Full Text] [Related]
17. Effects of right-hemisphere cortical infarction and muscarinic acetylcholine receptor blockade on spatial visual attention performance in rats. Hoff EI; van Oostenbrugge RJ; Liedenbaum M; Steinbusch HW; Blokland A Behav Brain Res; 2007 Mar; 178(1):62-9. PubMed ID: 17196269 [TBL] [Abstract][Full Text] [Related]
18. Impaired muscarinic regulation of excitatory synaptic transmission in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Goto Y; Niidome T; Hongo H; Akaike A; Kihara T; Sugimoto H Eur J Pharmacol; 2008 Mar; 583(1):84-91. PubMed ID: 18282567 [TBL] [Abstract][Full Text] [Related]
19. Muscarinic versus nicotinic modulation of a visual task. a pet study using drug probes. Mentis MJ; Sunderland T; Lai J; Connolly C; Krasuski J; Levine B; Friz J; Sobti S; Schapiro M; Rapoport SI Neuropsychopharmacology; 2001 Oct; 25(4):555-64. PubMed ID: 11557169 [TBL] [Abstract][Full Text] [Related]
20. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers. Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]